MedTrace Logo

Validation Study of mHealth Technology in HIV to Improve Empowerment and Healthcare Utilisation: Research and Innovation to Generate Evidence for Personalised Care (EmERGE)

NCT02904733 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3900

Last updated 2017-12-15

No results posted yet for this study

Summary

A large (3900 patients) cohort study, undertaken in five European sites to validate in a mHealth platform to enable self-management of HIV in patients with stable disease using a tailored HTA process, Model for Assessment of Telemedicine Applications (MAST), specifically developed for the assessment of mHealth solutions.

As site recruitment will be sequential and the recruitment period will last 18 months, a maximum follow-up of 35 Months will be undertaken. Study visits will take place at baseline defined as the time of mHealth introduction, months 6, 12, 18, 24 and 30.

Conditions

  • HIV Infections

Interventions

OTHER

mHealth platform

Use of a mHealth platform to inform and empower patient of hies/her own health

Sponsors & Collaborators

  • Brighton and Sussex University Hospitals NHS Trust

    collaborator OTHER

  • Instituut Voor Tropische Geneeskunde (ITM), Antwerp, Belgium.

    collaborator UNKNOWN

  • Klinika za infektivne bolesti (KIB), Zagreb, Croatia

    collaborator UNKNOWN

  • Centro Hospitalar de Lisboa Central

    collaborator OTHER

  • Fundacion Clinic per a la Recerca Biomédica

    collaborator OTHER

  • University of Brighton

    collaborator OTHER

  • Podmedics, ( POD), Northwood, United Kingdom

    collaborator UNKNOWN

  • Universidad Politecnica de Madrid

    collaborator OTHER

  • National Prospective Monitoring System HIV Health-economics Collaboration, (NPMS), Richmond, United Kingdom

    collaborator UNKNOWN

  • European Aids Treatment Group (EATG), Brussels, Belgium

    collaborator UNKNOWN

  • mHealth Futures LTD, Brighton, United Kingdom

    collaborator UNKNOWN

  • Hospital Clinic of Barcelona

    lead OTHER

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-07
Primary Completion
2019-09-30
Completion
2019-09-30

Countries

  • Belgium
  • Croatia
  • Portugal
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02904733 on ClinicalTrials.gov